View |
|
DRP-14307
|
Cefoperazone (as sodium) + Sulbactam (as sodium)
|
Saphtazone-1500
|
1 g/500 mg
|
Powder for Injection (IM/IV)
|
-
|
Bueno Salud Care (India) Pvt. Ltd.
|
India
|
Initial
|
16 August 2023
|
16 August 2028
|
View |
|
DRP-14308
|
Cefoperazone (as sodium) + Sulbactam (as sodium)
|
Saphtazone-1500
|
1 g/500 mg
|
Powder for Injection (IM/IV)
|
-
|
Kilitch Drugs (India) Ltd.
|
India
|
Initial
|
16 August 2023
|
16 August 2028
|
View |
|
DRP-14306
|
Cefuroxime (as sodium) with Sterile Water for Injection
|
Furimax-1500 Plus
|
1.5 g
|
Powder for Injection (IM/IV)
|
-
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
16 August 2023
|
16 August 2028
|
View |
|
DRP-14311
|
Cefuroxime (as Sodium)
|
Furimax-1500
|
1.5g
|
Powder for Injection (IM/IV)
|
-
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
16 August 2023
|
16 August 2028
|
View |
|
DRP-14309
|
Ceftazidime (as pentahydrate) with sodium carbonate
|
Ceftazimed-1
|
1g
|
Lyophilized Powder for Injection (IM/IV) n
|
-
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
16 August 2023
|
16 August 2028
|
View |
|
DRP-14310
|
Ceftazidime (as pentahydrate with sodium carbonate) with Sterile
Water for Injection
|
Ceftazimed-1 Plus
|
1g
|
Lyophilized Powder for Injection (IM/IV)
|
-
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
16 August 2023
|
16 August 2028
|
View |
|
DRP-14317
|
Paracetamol + Caffeine + Phenylephrine hydrochloride +
Chlorphenamine maleate
|
NoFlu Plus
|
500 mg 30 mg / 10 mg / 2 mg
|
Tablet
|
-
|
Phil. United Pharma Corp.
|
Philippines
|
Initial
|
17 August 2023
|
17 August 2028
|
View |
|
DRP-14315
|
Paracetamol + Caffeine + Phenylephrine hydrochloride +
Chlorphenamine maleate
|
None
|
500 mg/30 mg / 10 mg / 2 mg
|
Tablet
|
-
|
Phil. United Pharma Corp.
|
Philippines
|
Initial
|
17 August 2023
|
17 August 2028
|
View |
|
DRP-14316
|
Paracetamol + Caffeine + Phenylephrine hydrochloride +
Chlorphenamine maleate
|
Cetaphen Plus
|
500 mg/30 mg / 10 mg / 2 mg
|
Tablet
|
-
|
PHIL. UNITED PHARMA CORPORATION
|
Philippines
|
Initial
|
17 August 2023
|
17 August 2028
|
View |
|
DRP-14286
|
Levodropropizine
|
Protus
|
30 mg/5 mL
|
Syrup
|
-
|
Lloyd Laboratories. Inc.
|
Philippines
|
Initial
|
11 August 2023
|
11 August 2028
|
View |
|
DRP-14287
|
Levodropropizine
|
None
|
30 mg/5 mL
|
Syrup
|
-
|
Lloyd Laboratories, Inc
|
Philippines
|
Initial
|
11 August 2023
|
11 August 2028
|
View |
|
DRP-14305
|
Silver Sulfadiazine
|
Accediazine
|
10 mg/g (1% w/w)
|
Cream
|
-
|
OPAL Laboratories Pvt Ltd
|
Pakistan
|
Initial
|
16 August 2023
|
16 August 2028
|
View |
|
DRP-14296
|
Trimetazidine hydrochloride
|
TMZ-MR
|
35 mg
|
Modified Release Tablet
|
-
|
Novagen Healthcare Private Limited
|
India
|
Initial (Correction)
|
23 January 2024
|
10 August 2028
|
View |
|
DRP-14291
|
Sitagliptin (as phosphate monohydrate) + Metformin
hydrochloride
|
None
|
50 mg/1 g
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
10 August 2023
|
10 August 2028
|
View |
|
DRP-14292
|
Sitagliptin (as phosphate monohydrate) + Metformin
hydrochloride
|
None
|
50 mg/1 g
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
10 August 2023
|
10 August 2028
|
View |
|
DRP-14294
|
Sitagliptin (as phosphate monohydrate) + Metformin
hydrochloride
|
None
|
50 mg/500 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
10 August 2023
|
10 August 2028
|
View |
|
DRP-14293
|
Sitagliptin (as phosphate monohydrate) + Metformin
hydrochloride
|
None
|
50 mg/500 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
10 August 2023
|
10 August 2028
|
View |
|
DR-XY48842
|
Valsartan
|
None
|
80 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
09 August 2023
|
09 August 2028
|
View |
|
DRP-14275
|
Valsartan
|
ValSolv
|
320 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
09 August 2023
|
09 August 2028
|
View |
|
DRP-14295
|
Medroxyprogesterone acetate
|
Profemme
|
10 mg
|
Tablet
|
-
|
Steril-Gene Life Sciences (P) Ltd.
|
India
|
Initial (Correction)
|
03 October 2023
|
10 August 2028
|